196 Results

People

  1. Drilon
    Drilon
  2. Aghajanian
    Aghajanian
  3. Abdel-Wahab
    Abdel-Wahab
  4. De Angelis
    De Angelis
  5. Fornier
    Fornier
  6. Motzer
    Motzer
  7. Zelenetz
    Zelenetz
  8. Abou-Alfa
    Abou-Alfa
  9. Basch
    Basch
  10. Fury
    Fury

Groups

  1. Department of Medicine (134)
  2. Solid Tumor Oncology Division (84)
  3. Hematologic Malignancies, Division of (48)
  4. Center for Hematologic Malignancies (41)
  5. Survivorship Research (25)
  6. GSK Faculty (23)
  7. Adult Leukemia (20)
  8. Thoracic Oncology (19)
  9. Genitourinary Oncology Service (18)
  10. Tow Center for Developmental Oncology (TCDO) (17)
  1. "dizziness"
Formats
  1. Journal Article (180)
  2. Review (12)
  3. Research Letter (2)
  4. Editorial (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (134)
  2. Solid Tumor Oncology Division (84)
  3. Hematologic Malignancies, Division of (48)
  4. Center for Hematologic Malignancies (41)
  5. Survivorship Research (25)
  6. GSK Faculty (23)

More Groups

People
  1. Alexander Drilon (10)
  2. Carol Aghajanian (7)
  3. Alan Ho (5)
  4. Andrew Zelenetz (5)
  5. Lisa De Angelis (5)
  6. Monica Fornier (5)

More People

Years
  1. 2025 (4)
  2. 2024 (21)
  3. 2023 (20)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (18)

More Years

Publications
  1. Clinical Cancer Research (16)
  2. Journal of Clinical Oncology (13)
  3. Lancet Oncology (13)
  4. Blood (9)
  5. Annals of Oncology (8)
  6. Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (18)
  2. Elsevier Science, Inc. (18)
  3. Oxford University Press (17)
  4. American Association for Cancer Research (16)
  5. Nature Publishing Group (16)
  6. American Society of Clinical Oncology (13)

More Publishers

Results (196)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Iliac-enteric fistula managed by endovascular covered stent placement using extra-vascular microwire snaring: A case report
    Journal Article

    Moussa, A. M.; Sofocleous, C. T.
    CVIR Endovascular (2020)

    Fulltext@MSK | Save
  • Tazemetostat for patients with relapsed or refractory follicular lymphoma: An open-label, single-arm, multicentre, phase 2 trial
    Journal Article

    Morschhauser, F.; Tilly, H.; Chaidos, A.; McKay, P.; Phillips, T.; Assouline, S.; Batlevi, C. L.; Campbell, P.; Ribrag, V.; Damaj, G. L.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of ruxolitinib treatment for polycythemia vera
    Journal Article

    Coltoff, A.; Mesa, R.; Gotlib, J.; Shulman, J.; Rampal, R. K.; Siwoski, O.; Yacoub, A.; Moliterno, A.; Yang, A.; Braunstein, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Huh, W. K.; Brady, W. E.; Fracasso, P. M.; Dizon, D. S.; Powell, M. A.; Monk, B. J.; Leath, C. A. 3rd; Landrum, L. M.; Tanner, E. J.; Crane, E. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET-altered thyroid cancers
    Journal Article

    Wirth, L. J.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Patel, J.; Leboulleux, S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
    Journal Article

    Ikeda, T.; Takemoto, S.; Senju, H.; Gyotoku, H.; Taniguchi, H.; Shimada, M.; Dotsu, Y.; Umeyama, Y.; Tomono, H.; Kitazaki, T.; more...
    Thoracic Cancer (2020)

    Fulltext@MSK | Save
  • Consensus recommendations for management and counseling of adverse events associated with lorlatinib: A guide for healthcare practitioners
    Guidelines

    Reed, M.; Rosales, A. L. S.; Chioda, M. D.; Parker, L.; Devgan, G.; Kettle, J.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: A multicentre, open-label, phase 1 study
    Journal Article

    Tan, D. S. W.; Leighl, N. B.; Riely, G. J.; Yang, J. C. H.; Sequist, L. V.; Wolf, J.; Seto, T.; Felip, E.; Aix, S. P.; Jonnaert, M.; more...
    The Lancet Respiratory Medicine (2020)

    Fulltext@MSK | Save
  • Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): Post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Bendamustine with dexamethasone in relapsed/ refractory systemic light-chain amyloidosis: Results of a phase II study
    Journal Article

    Lentzsch, S.; Lagos, G. G.; Comenzo, R. L.; Zonder, J. A.; Osman, K.; Pan, S.; Bhutani, D.; Pregja, S.; Sanchorawala, V.; Landau, H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save